Archives of Pharmacal Research 2012-05-01

New topoisomerases inhibitors: synthesis of rutaecarpine derivatives and their inhibitory activity against topoisomerases.

Seung Ill Kim, Seung Ho Lee, Eung-Seok Lee, Chong-Soon Lee, Yurngdong Jahng

Index: Arch. Pharm. Res. 35(5) , 785-9, (2012)

Full Text: HTML

Abstract

A series of rutaecarpine derivatives were prepared by employing previously reported methods and their inhibitory activities against topoisomerase I and II were evaluated. Among them, strongly cytotoxic 10-bromorutaecarpine and 3-chlororutaecarpine showed strong inhibitory activities against topo I and II.

Related Compounds

  • Rutaecarpine

Related Articles:

Pharmacological effects of rutaecarpine as a cardiovascular protective agent.

2010-03-01

[Molecules 15(3) , 1873-81, (2010)]

Transdermal behaviors comparisons among Evodia rutaecarpa extracts with different purity of evodiamine and rutaecarpine and the effect of topical formulation in vivo.

2012-07-01

[Fitoterapia 83(5) , 954-60, (2012)]

Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.

2011-01-01

[Arch. Pharm. Res. 34(1) , 119-25, (2011)]

Synthesis and biological properties of benzo-annulated rutaecarpines.

2010-01-01

[Biol. Pharm. Bull. 33(10) , 1704-9, (2010)]

Rutaecarpine prevents hypoxia-reoxygenation-induced myocardial cell apoptosis via inhibition of NADPH oxidases.

2011-03-01

[Can. J. Physiol. Pharmacol. 89(3) , 177-86, (2011)]

More Articles...